Skip to main content
Premium Trial:

Request an Annual Quote

DNA Link Buys Orchid SNPStream System

NEW YORK, June 4 - DNA Link of Seoul, South Korea, has agreed to buy Orchid’s SNPstream 25K SNP-scoring system, the companies said.

"We acquired Orchid’s SNPstream 25K automated genotyping solution to enable us to accelerate our varied programs in medical genetics," Jong Eun Lee, co-CEO of DNA Link, said recently in a statement.

“We expect that the SNPstream system’s mix of accuracy, robustness, and cost effectiveness combined with access to Orchid’s growing SNP databases will contribute to the rapid progress of our gene discovery and pharmacogenetics programs,” he said.

DNA Link, a medical genetics research company, is Orchid’s first customer in Asia to buy the SNPstream system, which can analyze up to 25,000 SNPs per day.  

Financial terms of the agreement were not disclosed.

In addition to the SNPstream system, Orchid BioSciences of Princeton, NJ, also offers SNP scoring and pharmacogenetic testing services.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.